Key facts
- FMR LLC has 17 issuer positions tracked on this page.
- Estimated disclosed ownership value: $576,622,255.
- Recent insider filing activity is available below.
Insider Trading & Ownership of FMR LLC
- Location
- Boston, MA
- Summary
- The estimated value of insider holdings of FMR LLC is at least $576,622,255 dollars as of 05 May 2026. FMR LLC is the Other* of Flywire Corp and owns shares of Flywire Corp (FLYW) stock worth about $135.06M. FMR LLC is the Other* of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $126.7M. FMR LLC is the Other* of Toast, Inc. and owns shares of Toast, Inc. (TOST) stock worth about $113.42M. FMR LLC is the Other* of Neumora Therapeutics, Inc. and owns shares of Neumora Therapeutics, Inc. (NMRA) stock worth about $67.38M. FMR LLC is the Other*, 10%+ Owner of Beam Therapeutics Inc. and owns shares of Beam Therapeutics Inc. (BEAM) stock worth about $48.07M. FMR LLC is the Other*, 10%+ Owner of Structure Therapeutics Inc. and owns shares of Structure Therapeutics Inc. (GPCR) stock worth about $46.46M. FMR LLC is the Other* of Bicara Therapeutics Inc. and owns shares of Bicara Therapeutics Inc. (BCAX) stock worth about $14.77M. FMR LLC is the Other* of Caribou Biosciences, Inc. and owns shares of Caribou Biosciences, Inc. (CRBU) stock worth about $9.84M. FMR LLC is the Other*, 10%+ Owner of Sana Biotechnology, Inc. and owns shares of Sana Biotechnology, Inc. (SANA) stock worth about $7.49M. FMR LLC is the Other* of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. stock worth about $5.71M. FMR LLC is the Other* of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.58M. FMR LLC is the Other*, 10%+ Owner of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $122.8K. FMR LLC is the Other* of Fidelity Private Credit Fund and owns shares of Fidelity Private Credit Fund stock worth about $20.3K.
- Signature
- /s/ Richard Bourgelas, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson.
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow FMR LLC and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: Flywire Corp ($135,059,447).
- Past-year value change for that position: .
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of FMR LLC
FLYW
Forms 3/4/5
Flywire Corp
- Relationship
- Other*
- Holdings value
- $135,059,447
- Past year net change
- Change %
- Report period
- 28 May 2021
PRME
Forms 3/4/5
Prime Medicine, Inc.
- Relationship
- Other*
- Holdings value
- $126,699,612
- Past year net change
- Change %
- Report period
- 24 Oct 2022
TOST
Forms 3/4/5
Toast, Inc.
- Relationship
- Other*
- Holdings value
- $113,421,254
- Past year net change
- Change %
- Report period
- 09 Nov 2021
NMRA
Forms 3/4/5
Neumora Therapeutics, Inc.
- Relationship
- Other*
- Holdings value
- $67,379,749
- Past year net change
- Change %
- Report period
- 19 Sep 2023
BEAM
Forms 3/4/5
Beam Therapeutics Inc.
- Relationship
- Other*, 10%+ Owner
- Holdings value
- $48,071,330
- Past year net change
- -$1,003,913
- Change %
- -2%
- Report period
- 27 Oct 2025
GPCR
Forms 3/4/5
Structure Therapeutics Inc.
- Relationship
- Other*, 10%+ Owner
- Holdings value
- $46,455,733
- Past year net change
- -$5,022,625
- Change %
- -9.8%
- Report period
- 14 Apr 2026
BCAX
Forms 3/4/5
Bicara Therapeutics Inc.
- Relationship
- Other*
- Holdings value
- $14,770,801
- Past year net change
- Change %
- Report period
- 16 Sep 2024
CRBU
Forms 3/4/5
Caribou Biosciences, Inc.
- Relationship
- Other*
- Holdings value
- $9,836,921
- Past year net change
- Change %
- Report period
- 27 Jul 2021
SANA
Forms 3/4/5
Sana Biotechnology, Inc.
- Relationship
- Other*, 10%+ Owner
- Holdings value
- $7,493,594
- Past year net change
- Change %
- Report period
- 08 Jan 2025
VERV
Forms 3/4/5
Verve Therapeutics, Inc.
- Relationship
- Other*
- Holdings value
- $5,707,290
- Past year net change
- Change %
- Report period
- 26 Jul 2022
XLO
Forms 3/4/5
Xilio Therapeutics, Inc.
- Relationship
- Other*
- Holdings value
- $1,583,366
- Past year net change
- Change %
- Report period
- 26 Oct 2021
RLYB
Forms 3/4/5
Rallybio Corp
- Relationship
- Other*, 10%+ Owner
- Holdings value
- $122,842
- Past year net change
- Change %
- Report period
- 04 Mar 2026
No ticker
Forms 3/4/5
Fidelity Private Credit Fund
- Relationship
- Other*
- Holdings value
- $20,316
- Past year net change
- Change %
- Report period
- 29 Jan 2024
MTSR
Forms 3/4/5
Metsera, Inc.
- Relationship
- Other*, 10%+ Owner
- Holdings value
- $0
- Past year net change
- -$11,817
- Change %
- -100%
- Report period
- 13 Nov 2025
AVLN
Forms 3/4/5
Avalyn Pharma Inc.
- Relationship
- Other*, 10%+ Owner
- Holdings value
- Past year net change
- Change %
- Report period
- 01 May 2026
No ticker
Forms 3/4/5
Fidelity Multi-Strategy Credit Fund
- Relationship
- Other*, 10%+ Owner
- Holdings value
- Past year net change
- Change %
- Report period
- 19 May 2023
TSBX
Forms 3/4/5
Turnstone Biologics Corp.
- Relationship
- Other*
- Holdings value
- Past year net change
- Change %
- Report period
- 09 Jan 2024
Insider Transactions Reported by FMR LLC:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.